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Available online at www.sciencedirect.comAmong the hundreds of posttranslational modifications, limited
proteolysis, also known as processing, is special: It is
irreversible, near ubiquitous, and by trimming peptide chains
from their ends or cutting proteins into two, proteolysis forms
shorter chains displaying new termini. The unique chemistry
and location of a-amino-termini and carboxyl-termini in a
protein engender special chemical and physical properties to a
protein. Hence, modification of protein termini is often
associated with new biological activities of a protein. We
highlight recent proteomic developments enabling high
throughput identification of protein termini. This has
revolutionized degradomics and protein characterization by
mapping the specificity of terminal modifications and of
proteases, and has been used to directly identify new protease
substrates and molecular pathways altered by proteolysis.
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Introduction
Proteomics has made astonishing advances in all areas
including peptide enrichment, fractionation, mass spec-
trometry and data analysis — many of which are reviewed
in this issue. With mass spectrometry based proteomics it
is now possible to identify more than 10,000 proteins from
human cells [1,2]. Recent advances in the field of protein
post-translational modifications (PTMs) have uncovered
their widespread occurrence and physiological relevance.
However, for comprehensive analysis of PTMs specific
peptide enrichment approaches and dedicated analyses
are required, without which PTMs are usually under-
sampled and overlooked, respectively. In the absence of
functional annotation of proteins from PTMs many key
Open access under CC BY-NC-ND license.www.sciencedirect.com functions of bioactive proteins will be opaque and hence
hypotheses based on traditional shotgun analyses, may be
misleading or even worse, totally wrong.
PTM of proteins constitutes a highly diverse and dynamic
regulatory layer affecting all aspects of a protein from
protein folding, localization, interaction and bioactivity
to its stability and ultimately degradation. Therefore, each
distinctly modified version of a protein, also called a protein
species, and not just the initial translated version, needs to
be considered as the functional units comprising the pro-
teome [3]. The diversity of reversible and irreversible
modifications as well as the extensive modification machin-
ery [4] and the possibility of combinatorial effects
dramatically increase proteome complexity by several
orders. Organisms as different as worm, fly and man have
comparable sized genomes yet show a great discrepancy in
phenotypic complexity. While splicing introduces bulk
complexity it might well be that the diversity created by
pinpoint posttranslational modifications accounts for the
observed phenotypic differences. Hence, advanced pro-
teomics has potential to explain phenotypes where con-
ventional genomics fall short — but it is not easy.
Every modification adds to the functional diversity of the
proteome by reversibly or irreversibly converting one
protein species into another that potentially is a function-
ally distinct species. In this regard, limited proteolysis is
special as it has the unique ability to irreversibly convert
one into two distinct protein species while at the same
time generating new protein termini serving as attach-
ment sites for even further PTM.
Second only to ubiquitin ligases in number, proteases and
their inhibitors constitute a large enzyme family with 567
members in humans. In what has been termed the
degradome, the assembly of all elements involved in
proteolysis — proteases, inhibitors and the processed
substrates — can now be specifically studied in high
throughput investigations termed degradomics [5]. Pro-
teases modify their substrates by hydrolysis of scissile
bonds releasing two peptide chains with the two amino
acids adjacent to the cleaved bond now becoming car-
boxy-terminal or amino-terminal residues. Unlike most
PTM attachment sites, the hydrolyzed peptide bond is
not amenable for direct assessment. For limited proteol-
ysis, termed processing, the site of modification is there-
fore determined by identification of the ‘neo’ termini of
the products. Consequently the degradome and termi-
nome are mutually dependent, with the identification of
termini adding considerable functional annotation to the
proteome.Current Opinion in Chemical Biology 2013, 17:73–82
74 OmicsEnriching for post-translational modifications
PTMs often occur at low stoichiometry and thus efficient
enrichment techniques are key for their successful and
comprehensive identification. In general different chemi-
cal affinities between the modified and unmodified
species are utilized for differential binding to a resin or
chromatographic media yielding positive or negative
selectivity and enrichment. All approaches share the
common hurdle of unspecific carryover and loss following
binding to surfaces. A great advance for the enrichment of
peptides bearing PTMs is the replacement of resins by
soluble hyper branched polyglycerol polymers leading to
massively decreased nonspecific binding while increasing
binding capacity [6].
Upon successful peptide enrichment mass spectrom-
etry is used for peptide and PTM identification. Unlike
identification of the entire protein by multiple peptides
in one shotgun experiment, identification of a specific
modification and often the protein bearing the PTM, isFigure 1
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For proteins having two or more such modifications,
protein identification can often be made by two or more
different and unique peptides. However, for single
peptides bearing a PTM, such as phosphopeptides,
unambiguous protein identification is problematic.
For the identification of protein termini we and others
introduced high confidence protein identification from
single peptide identifications based on multiple peptide
variants [7,8]. In the past ten years since its introduc-
tion [5] degradomics and its subfield, terminomics, have
developed from a small field covered by only a few
publications a year to a vibrant community publishing
over 40 papers in 2011 (Figure 1). For in depth com-
parison of available mass spectrometry based methods
for the proteome-wide analysis of limited proteolysis
and their subsequent modification we refer to a recent
review by Huesgen and Overall [9] and by the
accompanying paper in this issue from the Gaevert
laboratory [10].(c)
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Protein termini and proteolysis Lange and Overall 75Characterization of the proteolytic machinery
Since the function of a protease is inherently linked to the
effect of proteolysis on its substrates, and since more than
half of all proteases have no annotated substrates in
MEROPS, the protease database (http://merops.sanger.-
ac.uk), since 2000 a major focus has been in the identi-
fication of protease substrates [11]. These include matrix
metalloproteinases (MMPs) 2, 9, 14, 25 [6,12–16], cath-
epsins D and E [8,17] and caspases 2, 3, 7 [18], meprins,
astacins, and the methionine aminopeptidase-2 [19]. In
vivo the cleavage rate differs greatly between individual
substrates by the same protease [20]. The cleavage site
specificity of proteases has been investigated in depth
using standard and specifically tailored degradomics
approaches using database searchable, proteome-derived
peptide libraries in a procedure called PICS [21]. This
leads to the detailed characterization of both the prime
and nonprime specificity of, for example, MMPs [21],
cathepsins [22], astacins [23], caspases [18,21] and meth-
ionine aminopeptidase-1 [24,25]. However, specific
analysis of cleavage sites in denatured peptides does
not identify native substrates. For this task, COFRADIC
[26] and TAILS [6] are highly successful negative selec-
tion approaches that also provide information on the
nature of posttranslational modifications of termini.
Of particular importance for the characterization of any
enzyme is the assessment of its kinetic properties in vivo.
Employing identification of protease derived termini
followed by time resolved quantification by single reac-
tion monitoring (SRM) Agard and colleagues monitored
the cleavage kinetics of caspases in lysates and living cells
[27]. Compounding the problems in analysis is the fact
that proteases do not act independently, but are inter-
connected in the protease web [28]. Comprehensive
proteome-wide analysis of global proteolysis by termi-
nomics in complex mammalian tissues, comparing pro-
tease knockout mice with wild types, is now enabled for
the first time for the in vivo investigation of such network
effects [29]. Hence, degradomics has advanced con-
siderably from the first experimental paper in 2004 pre-
senting ICAT labeled protein fragments shed from
membrane proteins [12].
Protein termini expose new interfaces
Despite methodological advances, data without context is
information, not knowledge. To combine the ever-grow-
ing body of information on protein termini and limited
proteolysis, to discover network effects and integrate this
with prior knowledge the ‘Termini oriented protein func-
tion inferred database’ (TopFIND — http://clipserve.cli-
p.ubc.ca/topfind) [30] acts as central repository and
information resource. Thereby, an evaluation of thirteen
terminomics datasets from Homo sapiens, Mus musculus,
and Escherichia coli shows that >30% of all N-termini and
>10% of all C-termini originate from post-translational
proteolytic processing other than classical proteinwww.sciencedirect.com maturation (removal of the initiator methionine, signal
peptide and pro-peptide) [31]. More recently, in skin
50% of the >2000 proteins identified had evidence of
stable cleavage products in vivo [29].
Terminal regions of a protein are often flexible, protrud-
ing and distinct from internal, continuous amino acid
stretches and therefore frequently act as recognition sites
for receptors and antibodies. Thus, by frequent formation
of new N-termini or C-termini, limited proteolysis closes
interfaces while opening up new ones that can be further
altered by amino acid modifications ranging from post-
translational acetylation to cyclization or palmitoylation.
While several hundred PTMs are listed in Unimod, which
serves as the comprehensive reference database for
protein modifications (http://www.unimod.org), certain
modifications are specific to the free amino or carboxyl
terminus and thus can only occur at one site each in a
protein. Thus, terminomics has been extensively used to
study co-translational and post-translational modification
of terminal amino acids.
N-terminal modifications
In addition to co-translational acetylation Unimod and
TopFIND report 11 amino-terminal PTMs including
acetylation, mono-methylation, di-methylation and tri-
methylation, formylation, carbamylation, succinylation,
cyclization, propionylation, palmitoylation and myristoy-
lation. Among these aN-acetylation and cyclization are
the only two studied in depth at the mechanistic and
proteome-wide level. aN-acetylation plays an important
regulatory role in protein stability and protein turnover
via the N-end rule [32,33]. Initially, only co-transla-
tional aN-acetylation was recognized. However, post-
translational aN-acetylation is now recognized as wide-
spread PTM occurring in vivo [6,25,29,34,35,36,37].
Comprehensive understanding of aN-acetylation also
enables the identification of alternate translational start
sites utilizing the differential patterns displayed by co-
translational and post-translational aN-acetylation [29].
Chen et al. [38] for the first time described a physiological
function for terminal methylation. The binding efficiency
of regulator of chromatin condensation 1 (RCC1) to H2A
and/or H2B depends on its terminal methylation with
defective methylation leading to spindle-pole defects.
Interestingly recent experiments suggest functional inter-
play or competition between aN-acetylation and aN-
methylation [39] and probably also aN-propionylation,
which early terminomics studies identified as occurring in
vivo [34].
Cyclization of a terminal glutaminyl or glutamate residue
forming N-pyroglutamate, a process initially believed to
occur spontaneously but now recognized to be catalyzed
by two glutaminylcyclases [40], attracts interest inCurrent Opinion in Chemical Biology 2013, 17:73–82
76 OmicsAlzheimer’s research following the identification of a
toxic pyroglutamate modified APP Ab species (see
below). In vivo sequence specificity for N-terminal cycli-
zation has now been recently determined by TAILS,
which enriches for all blocked termini, regardless of
the modification [29]. Finally, attachment of fatty acid
or prenyl moieties is not strictly limited to the terminal
amino acid, but N-myristoylation and N-palmitoylation
are known to mediate signaling and trafficking [41,42],
making their location at a terminus special, as these sites
and cell attachment can be lost upon cleavage. While this
group of PTMs has been extensively studied by classical
biochemical and cell biological approaches its proteome
wide relevance remains to be shown.
C-terminal modifications
The C terminus of proteins is inherently less reactive
than the N terminus. While this may lead to less exten-
sive modification in nature, this too is the very reason for
the lack of C-terminal sequencing ability and hence
recognition of C terminal modifications, until recently.
Even with the recent advent of high throughput identi-
fication of C-termini [34,43,44] we still have very limitedFigure 2
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terminus.
C-methyl-esterification is the most frequently annotated
modification, but with only 17 proteins in human, 6 in
mouse and 7 in yeast reported by TopFIND, yet the C-
termini remain underexplored. Examples include the
methylation of the C-terminal leucine residue in the
serine-threonine phosphatase 2A catalytic subunit
(PP2Ac), which is required for the interaction with its
regulatory Ba subunit [45].
C-terminal isoprenylation, cholesterol-esterification and
addition of GPI anchors are involved in membrane tar-
geting and trafficking but most of these were studied by
classical biochemical analyses over the past 20 years [46].
We suggest that the limited number of described C-
terminal PTMs does not reflect reality, but rather is
due to the lack of appropriate technologies for the in
depth analysis of C-termini and their modifications until
recently. Given the high number of carboxypeptidases
greatly exceeding what can possibly be needed for mere
degradation, the identification of C-terminal processingMe P
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Protein termini and proteolysis Lange and Overall 77[43] and the physiological importance of the few modi-
fications already known, in depth investigation of C-
terminal modifications promises great potential for exit-
ing new mechanistic insights into protein function.
Knowledge of protein termini limits
complexity
The notion that every PTM and combination thereof
added to a protein needs to be considered as independentFigure 3
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Functional competence of a protein flagged by protein termini: simplified representation of processing of the amyloid precursor protein (APP) in the
nonamyloidogenic (left, green) and amyloidogenic (right, red) pathways by a-secretases, b-secretases and g-secretases. For full details see TopFIND
(http://clipserve.clip.ubc.ca/topfind/proteins/P05067). In the non-pathologic nonamyloidogenic pathway APP is first cleaved by a-secretase near the
plasma membrane. This releases the soluble APPsa species having a unique C687-termninus and unknown function. Subsequent intramembrane
cleavage by y-secretase generates the p3 peptide with a unique N688-terminus and the APP intracellular domain, which is most likely degraded. The
first processing step in the amyloidogenic pathway is mediated by b-secretase, BACE-1, in the endosome at a slightly different position to release
APPsb and Ab species with the unique C671-termini and N672-termini, respectively. APPsb undergoes further sequential maturation by an unknown
protease at an undefined position generating the N-APP species, which binds to the death receptor 6 (DR6) on cells in trans triggering axon pruning
Current Opinion in Chemical Biology 2013, 17:73–82 www.sciencedirect.com
Protein termini and proteolysis Lange and Overall 7957 genes are known, including many containing multiple
phosphorylations and methylations [50]. Multiple
modifications can cooperate by two fundamental prin-
ciples. First, the total number of modifications can be
critical to reach a certain threshold for a change in protein
function. For example charge accumulation or masking
alters the dipole moment of a molecule thereby attracting
or repelling specific protein–protein interactions. Second,
the exact combination of modifications can be required in
order to reach a physiological outcome hence conveying
true combinatorial specificity.
While distinct modification sites and identified species
are now in the hundreds for histones and the HMG
family, these numbers are dwarfed by the theoretical
number of possible species formed by combinatorial
use of PTM sites. Considering only HMGA1 and PTM
sites annotated by neXtProt (http://nextprot.org) a total of
>105 protein species could potentially exist (Figure 2a).
In some cases an unmodified protein forms a reservoir of
inactive protein awaiting activation by modification, in
others the PTM switches activity of the protein from
one type to another. Combined combinatorial consider-
ations lead to many new species having graduations of
activity.
While top-down proteomics provides direct identification
of a protein species including all of its PTMs, assigning
peptide identifications from shotgun analyses to specific
protein species remains problematic. However, as exem-
plified in Figure 2b for a TopFIND analysis of HMGB1
(http://clipserve.clip.ubc.ca/topfind/proteins/P17096),
knowledge of the terminal peptides of the species present
in the sample provides boundaries drastically reducing
the search space.
Protein termini are markers for functional
competence
Modification of a protein by limited proteolysis can be
divided into two general classes: first, sequential matu-
ration and second, protein partitioning. During sequential
maturation the removal of, for example, a propeptide that
maintains enzyme latency, enables enzymatic activity of
the major chain, but the propeptide, its task done, is most
often then degraded (Figure 3a). Similarly, chemokine
functions are frequently altered by truncation of few amino
acids at their N-terminus or C-terminus (Figure 3b and c).
CCL2 and CCL7, for example, become antagonists after( Figure 4 Legend Continued ) and neuron death. Ab in turn form oligomer
component of the amyloidogenic pathway. The Ab species can undergo fur
terminal glutamate residue that is recently claimed to be the toxic species. This
aggregation. Following b-secretase cleavage of APP, g-secretase releases the
nucleus regulating transcription. The key lists the major APP species, some are 
in schema) associating the terminus with either the amyloidogenic (red backgro
presence or absence of functional groups and prior knowledge, the functional 
terminus. Flag symbols indicate the unique protein termini of the protein spec
www.sciencedirect.com N-terminal truncation [11]. In contrast, partitioning leads
to the formation of two new protein species with usually
unrelated properties thereby increasing the complexity of
the proteome and potential for functional diversity
(Figure 3d). HARP cleavage by MMP2 generates two
bioactive species having opposing activity — the N-term-
inal species increases mitogenesis whereas the C-terminal
species is antagonistic [13]. Irrespective of its mode of
formation each new protein species is characterized by one
‘neo’ terminus. New functionality can be introduced by
further modification of the new terminus including the
recent recognition of post-translational acetylation [29]
thereby increasing the functional repertoire of the new
protein species. However, as the species inherits only a
subset of its progenitors features, such as active sites,
binding regions and PTM sites, the potential functional
complexity is limited.
In the following we use the amyloid beta A4 protein
(APP) to illustrate how protein termini identified by
terminomics can serve as markers for the functionality
a protein species. We refer to this as the ‘functional
competence’ of a protein species which can be obtained
by ‘positional cross correlation’ of a species’ termini with
prior functional knowledge [31].
APP is well known for its role in Alzheimer’s disease [51].
APP is a single pass type-I transmembrane protein that
undergoes a series of partitioning processing steps leading
to multiple bioactive species (Figure 4). Comparing the
normal nonamyloidogenic with disease causing amyloi-
dogenic situations, the participation of different proteases
in different subcellular compartments and facing chan-
ging physicochemical conditions translate to minute
differences in species length and dramatic changes in
systemic effect. Many more cleavages and species have
been described for APP [52] (see TopFIND: http://clip-
serve.clip.ubc.ca/topfind/proteins/P05067#processing),
for example of the N-APP species by meprin b [53].
However, even the simplified version depicted in
Figure 4 highlights the complexity of the different func-
tional and disease outcomes associated with different
APP species. Clearly then, conventional shotgun proteo-
mics cannot easily allow for distinguishing which APP
species gave rise to a specific peptide and thus fails to
capture this complexity and providing only incomplete
information. This void can be filled by identification and
quantification of the protein termini which allows nots or accumulate in sheets and is believed to be the major pathogenic
ther trimming at its amino-terminus followed by cyclization of the now
 AbpE3 species is flagged by a unique N674pyro terminus and can initiate Ab
 AICD species to the cytoplasm, which is degraded or translocated to the
unambiguously identified by one of their termini (bold in legend, flag symbol
und) or nonamyloidogenic (green background) pathway. On the basis of the
competence can be defined (last column) and associated with the flagged
ies (blue flag, N-terminus; red flag, C-terminus).
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80 Omicsonly for dissection of the different species present but also
to infer their function and the proteolytic process by
which they were generated. If the protease concerned
is a drug target then specific monitoring of these terminal
peptides forms an invaluable biomarker for drug efficacy
and treatment progression.
Unfortunately knowledge of one terminus is not always
enough to unambiguously identify a protein species. For
example, to differentiate the pathophysiological differing
species Ab40
N672-C711and Ab42
N672-C713 additional knowl-
edge of their C-terminus is required (Figure 4). Thus, in
complex mixtures terminomics faces the same limitations
as classical shotgun proteomics but while incredible
advances have been made in top-down analyses [50]
they are still not readily available. So for now we can
conclude that knowledge of the N-terminus and/or C-
terminus reveals important information about a protein
species including, first, the proteolytic processes leading
to its formation; second, the protein features present and
lost; third, its functional competence; fourth, and often its
predicted stability and thus is essential for generating
biologically relevant hypotheses on the protein’s function
in vivo.
Conclusions
The advent of proteomics for the enrichment and inves-
tigation of protein termini triggered a number of exiting
findings and developments. First, when the investi-
gation of limited proteolysis on a proteome-wide level
became amenable this resulted in an explosion of newly
identified protease substrates, an unexpected number of
which are protease inhibitors or proteases themselves.
This in turn enforced our understanding of proteolysis
as a process occurring in a tightly interdependent net-
work we have termed the protease web. With charac-
terization of specificity and in vivo kinetics, great
advances have also been made on the level of the
individual enzyme in vivo.
One area that holds great potential, indeed well deser-
ving of greater attention, is the global characterization
of terminal modifications other than N-acetylation, in
particular for carboxy-terminal modifications. These are
particularly interesting and their unique properties —
there is only one of each per protein chain and they
only can come into existence after proteolytic
processing — add a fascinating level of regulatory com-
plexity.
A challenge of great enormity is to delve into the vast
complexity engendered by PTMs. We have described
how knowledge of protein termini will facilitate this by
setting boundaries to the search space and acting as
biomarkers defining the functional state of a protein. In
the near future this will lead to exiting new biological
insights into cellular and disease processes at a systemsCurrent Opinion in Chemical Biology 2013, 17:73–82 level and help close the gap between genotypes and
phenotypes.
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